Back to Search Start Over

Stroke aetiological classification reliability and effect on trial sample size: systematic review, meta-analysis and statistical modelling

Authors :
Abdul-Rahim, AH
Dickie, DA
Selvarajah, JR
Lees, KR
Quinn, TJ
Alexandrov, A
Bath, PM
Berge, E
Bluhmki, E
Bornstein, N
Chen, C
Claesson, L
Davis, SM
Donnan, G
Diener, HC
Fisher, M
Ginsberg, M
Gregson, B
Grotta, J
Hacke, W
Hennerici, MG
Hommel, M
Kaste, M
Lyden, P
Marler, J
Muir, K
Venketasubramanian, N
Sacco, R
Shuaib, A
Teal, P
Wahlgren, NG
Warach, S
Weimar, C
Abdul-Rahim, AH
Dickie, DA
Selvarajah, JR
Lees, KR
Quinn, TJ
Alexandrov, A
Bath, PM
Berge, E
Bluhmki, E
Bornstein, N
Chen, C
Claesson, L
Davis, SM
Donnan, G
Diener, HC
Fisher, M
Ginsberg, M
Gregson, B
Grotta, J
Hacke, W
Hennerici, MG
Hommel, M
Kaste, M
Lyden, P
Marler, J
Muir, K
Venketasubramanian, N
Sacco, R
Shuaib, A
Teal, P
Wahlgren, NG
Warach, S
Weimar, C
Publication Year :
2019

Abstract

BACKGROUND: Inter-observer variability in stroke aetiological classification may have an effect on trial power and estimation of treatment effect. We modelled the effect of misclassification on required sample size in a hypothetical cardioembolic (CE) stroke trial. METHODS: We performed a systematic review to quantify the reliability (inter-observer variability) of various stroke aetiological classification systems. We then modelled the effect of this misclassification in a hypothetical trial of anticoagulant in CE stroke contaminated by patients with non-cardioembolic (non-CE) stroke aetiology. Rates of misclassification were based on the summary reliability estimates from our systematic review. We randomly sampled data from previous acute trials in CE and non-CE participants, using the Virtual International Stroke Trials Archive. We used bootstrapping to model the effect of varying misclassification rates on sample size required to detect a between-group treatment effect across 5000 permutations. We described outcomes in terms of survival and stroke recurrence censored at 90 days. RESULTS: From 4655 titles, we found 14 articles describing three stroke classification systems. The inter-observer reliability of the classification systems varied from 'fair' to 'very good' and suggested misclassification rates of 5% and 20% for our modelling. The hypothetical trial, with 80% power and alpha 0.05, was able to show a difference in survival between anticoagulant and antiplatelet in CE with a sample size of 198 in both trial arms. Contamination of both arms with 5% misclassified participants inflated the required sample size to 237 and with 20% misclassification inflated the required sample size to 352, for equivalent trial power. For an outcome of stroke recurrence using the same data, base-case estimated sample size for 80% power and alpha 0.05 was n = 502 in each arm, increasing to 605 at 5% contamination and 973 at 20% contamination. CONCLUSIONS: Stroke aetiological cl

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1315719218
Document Type :
Electronic Resource